ArticleJournal of cardiovascular electrophysiology2025
Trends and Disparities in Ventricular Tachycardia-Related Mortality According to Cardiomyopathy Type in the United States.
Article in Journal of cardiovascular electrophysiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Trends and Disparities in Ventricular Tachycardia-Related Mortality According to Cardiomyopathy Type in the United States.Journal of cardiovascular electrophysiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRecent data show increased ventricular tachycardia (VT) related mortality. We aimed to investigate the trends and disparities of VT-related mortality according to cardiomyopathy subtypes.
methodsMortality and demographic data were obtained from the CDC Wide-ranging Online Data for Epidemiologic Research database between 1999 and 2020. VT-related mortality was defined as the underlying cause of death and ischemic cardiomyopathy (ICM) or nonischemic cardiomyopathy (NICM) as the contributing cause of death. The direct method of standardization was utilized to estimate age-adjusted mortality rates (AAMRs). Temporal trends were evaluated using log-linear regression models.
resultsA total of 15 888 deaths were related to both VT and ICM, and 16 777 were due to both VT and NICM. There was a significant increase in VT and ICM-related mortality between 2006 and 2020 with an APC of +1.38% (p < 0.05). Similarly, VT and NICM-related mortality increased between 2008 and 2020 with an APC of +0.60% (p < 0.05). ICM had a higher AAMR in males [6.23 (6.12-6.34)], Whites [3.49 (3.43-3.54)], Hispanics [2.11 (1.95-2.26)], and the Midwest region [3.73 (3.61-3.85)] compared to NICM. In contrast, NICM had a higher AAMR in females [1.57 (1.52-1.61)], Black or African Americans [5.02 (4.84-5.20)], and the South region [3.10 (3.03-3.18)]. p for all trend < 0.05.
conclusionsReal-world data show significant differences in VT-related mortality according to cardiomyopathy subtypes with prominent sex, race, and regional disparities. Clinical and public health strategies are needed to address inequities and improve outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.